Bird & Bird wins MedQuist deal

Bird & Bird has advised US medical transcription services provider MedQuist, a Philips subsidiary, on its acquisition of Speech Machines. Corporate partner Roger Butterworth provided advice as to English law in a deal valued at approximately $10m (£7.2m).`Although MedQuist is quoted in the US, Anglo-Dutch giant Koninklijke Philips Electronics NV holds the majority of its shares.`Bird & Bird’s relationship with Philips goes back to before World War II. Butterworth said: “We were delighted to extend our relationship with Philips to its US subsidiary, MedQuist.”`Advice on US law was provided by MedQuist’s regular US counsel Pepper Hamilton. Speech Machines was advised by a Brobeck Hale and Dorr team led by corporate partner Tom Kellerman.`Nasdaq-listed MedQuist delivers a service that records and stores free-form medical dictation, transcribes the dictation into reports, and electronically distributes final reports to clients.`Speech Machines is an application service provider (ASP) of dictation recording, editing and workflow management for the medical transcription industry. The acquisition cements MedQuist’s position as the largest supplier of electronic medical transcription services to the healthcare industry in the US.